Phase Ib/II Clinical Study of LBL-007 in Treatment of Advanced Malignant Tumors
Status:
Not yet recruiting
Trial end date:
2023-07-14
Target enrollment:
Participant gender:
Summary
This trial is a single-arm, open, multi-center phase Ib/II clinical study, which aims to
evaluate the safety, tolerability, PK characteristics, immunogenicity, and Effectiveness.